Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study
Open Access
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier BV in Annals Of Oncology
- Vol. 12 (11), 1619-1630
- https://doi.org/10.1023/a:1013148730966
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Ewing sarcoma of the ribResults of an intergroup study with analysis of outcome by timing of resectionThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in childrenEuropean Journal Of Cancer, 2000
- Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomasMedical and Pediatric Oncology, 2000
- Chemotherapy Dose-Intensification for Pediatric Patients With Ewing's Family of Tumors and Desmoplastic Small Round-Cell Tumors: A Feasibility Study at St. Jude Children's Research HospitalJournal of Clinical Oncology, 1999
- Prognostic Factors in Patients with Localized Ewing’s Sarcoma: The effect on survival of actual received drug dose intensity and of histologic response to induction therapyJournal of Chemotherapy, 1997
- Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumorsCancer, 1996
- Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.Journal of Clinical Oncology, 1995
- Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.Journal of Clinical Oncology, 1992
- Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's SarcomaJNCI Journal of the National Cancer Institute, 1991
- Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.Journal of Clinical Oncology, 1991